Document Detail


Obstetric Nephrology: Lupus and Lupus Nephritis in Pregnancy.
MedLine Citation:
PMID:  22879437     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
SLE is a multi-organ autoimmune disease that affects women of childbearing age. Renal involvement in the form of either active lupus nephritis (LN) at the time of conception, or a LN new onset or flare during pregnancy increases the risks of preterm delivery, pre-eclampsia, maternal mortality, fetal/neonatal demise, and intrauterine growth restriction. Consequently, current recommendations advise that the affected woman achieve a stable remission of her renal disease for at least 6 months before conception. Hormonal and immune system changes in pregnancy may affect disease activity and progression, and published evidence suggests that there is an increased risk for a LN flare during pregnancy. The major goal of immunosuppressive therapy in pregnancy is control of disease activity with medications that are relatively safe for a growing fetus. Therefore, the use of mycophenolate mofetil, due to increasing evidence supporting its teratogenicity, is contraindicated during pregnancy. Worsening proteinuria, which commonly occurs in proteinuric renal diseases toward the end of pregnancy, should be differentiated from a LN flare and/or pre-eclampsia, a pregnancy-specific condition clinically characterized by hypertension and proteinuria. These considerations present challenges that underscore the importance of a multidisciplinary team approach when caring for these patients, including a nephrologist, rheumatologist, and obstetrician who have experience with these pregnancy-related complications. This review discusses the pathogenesis, maternal and fetal risks, and management pertinent to SLE patients with new onset or a history of LN predating pregnancy.
Authors:
Todd J Stanhope; Wendy M White; Kevin G Moder; Andrew Smyth; Vesna D Garovic
Related Documents :
23180347 - Therapeutic management of epithelial ovarian cancer during pregnancy.
24900977 - Implementation study of patient-ready syringes containing 25 mg/ml methotrexate solut...
15925047 - Short stature--an independent risk factor for cesarean delivery.
23828097 - Biologically based treatment approaches to the patient with resistant perinatal depress...
7701457 - Outcome of pregnancy in women with cystic fibrosis.
9795887 - Unconscious pregnancy fantasies as an underlying dynamism in panic disorder.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-9
Journal Detail:
Title:  Clinical journal of the American Society of Nephrology : CJASN     Volume:  -     ISSN:  1555-905X     ISO Abbreviation:  Clin J Am Soc Nephrol     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101271570     Medline TA:  Clin J Am Soc Nephrol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota;, †Division of Maternal Fetal Medicine, Mayo Clinic, Rochester, Minnesota;, ‡Divisions of Rheumatology and, ‖Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, §Department of Medicine, National University of Ireland, Galway, Ireland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study o...
Next Document:  Onco-Nephrology: The Pathophysiology and Treatment of Malignancy-Associated Hypercalcemia.